i-violin: Implementing verifiable oncological imaging by quality assurance and optimisation [EN]
Partners: European Institute for Biomedical Imaging Research (coordenador de projeto), Austria; Otto-von-Guericke University Magdeburg (coordenação científica), Germany; University Medicine Mainz (of the Johannes Gutenberg University of Mainz), Germany; Polytechnic Institute of Coimbra, Portugal;University of Crete, Greece; Clinical Hospital Dubrava (KB Dubrava), Croatia; University Medical Centre Ljubljana, Slovenia; KU Leuven, Belgium; University College Dublin, National University of Ireland, Dublin, Ireland; Finnish Radiation and Nuclear Safety Authority, Finland
Start Date: September 1, 2022
End Date: August 31, 2024
Total Funding: € 1,172,487.81
ESTeSC-IPC responsible investigators: Graciano Paulo e Joana Santos
Project objectives
(1) To implement a standardised way of optimisation in oncological imaging approaches in clinical practice by adapting and deploying tools for quantifiable image quality assessment as well as by validating commercially available software solutions for patient dose determination in imaging procedures, using the output of the MEDIRAD and other EC-funded projects.
(2) To implement such tools and the proposed optimised procedures in (university) hospitals throughout Europe that are members of the i-Violin consortium.
(3) To disseminate these tools and optimised procedures to interested hospitals and healthcare providers in Europe to contribute towards a harmonised and standardised oncological imaging approach.
(4) To provide a suitable education and training programme for radiologists, radiographers and medical physicists to be able to use the harmonisation tools.
(5) To disseminate the results to policymakers, the medical societies and other relevant stakeholders to foster uptake and implementation.
Detailed information about the project avaiable here.
*Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
Press realeases
i-Violin project launched on 1 September 2022